---
title: "REPLIGEN CLINICAL PARTNERS LP — Ownership Dossier"
canonical: https://whiteintel.dev/entity/5e694eda-8ac2-549a-8bbc-a35e66b60f51
json: https://whiteintel.dev/api/public/dossier/5e694eda-8ac2-549a-8bbc-a35e66b60f51
identifier: sec:0000885434
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# REPLIGEN CLINICAL PARTNERS LP

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0000885434`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/5e694eda-8ac2-549a-8bbc-a35e66b60f51  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/5e694eda-8ac2-549a-8bbc-a35e66b60f51  

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **REPLIGEN CLINICAL PARTNERS LP**. Human view: https://whiteintel.dev/entity/5e694eda-8ac2-549a-8bbc-a35e66b60f51 · Structured JSON: https://whiteintel.dev/api/public/dossier/5e694eda-8ac2-549a-8bbc-a35e66b60f51._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._